Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach

Overview

Journal Blood Cancer Discov

Date 2025 Feb 3

PMID 39898759

Authors

Christopher R Flowers

Rachel W Anantha

Veronica Leautaud

Pinkal Desai

Chancellor E Donald

Michelle A T Hildebrandt

Jean L Koff

Rulla M Tamimi

Wendy Cozen

Chijioke Nze

Ari M Melnick

Affiliations

Soon will be listed here.

Abstract

This review underscores our shared responsibility to champion multidimensional strategies rooted in basic and translational science, community involvement, and societal responsiveness for a meaningful impact. Unifying themes include the need to enhance collaborative infrastructure to engage laboratory researchers, epidemiologists, data scientists, clinicians, patients, community leaders, and policymakers; patient-level support services; outreach, education, and navigation for patients at the community level; recruitment and retention of underrepresented groups in the healthcare and research workforce; and funding for these efforts.

References

Nabhan C, Byrtek M, Taylor M, Friedberg J, Cerhan J, Hainsworth J . Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. Cancer. 2012; 118(19):4842-50. DOI: 10.1002/cncr.27513. View

Frederiksen B, Dalton S, Osler M, Steding-Jessen M, de Nully Brown P . Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study. Br J Cancer. 2012; 106(5):988-95. PMC: 3305955. DOI: 10.1038/bjc.2012.3. View

Flowers C, Nastoupil L . Socioeconomic disparities in lymphoma. Blood. 2014; 123(23):3530-1. PMC: 4047493. DOI: 10.1182/blood-2014-04-568766. View

Ge Z, Song C, Ding Y, Tan B, Desai D, Sharma A . Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021; 35(5):1267-1278. PMC: 8102195. DOI: 10.1038/s41375-021-01132-5. View

Zhao Y, Wang Y, Ma S . Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology. Sci Rep. 2018; 8(1):548. PMC: 5765036. DOI: 10.1038/s41598-017-19081-4. View

Villela L, Torre-Viera M, Idrobo-Quintero H, Beltran B . Non-Hodgkin lymphoma treatment in middle-income countries in Latin America: perspective of the Latin American Study Group of Lymphoproliferative Disorders [ (GELL)]. Hematology. 2022; 27(1):1208-1216. DOI: 10.1080/16078454.2022.2141960. View

Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W . ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2012; 30(7):751-7. PMC: 3295551. DOI: 10.1200/JCO.2011.38.0345. View

Greenwood B, Hardeman R, Huang L, Sojourner A . Physician-patient racial concordance and disparities in birthing mortality for newborns. Proc Natl Acad Sci U S A. 2020; 117(35):21194-21200. PMC: 7474610. DOI: 10.1073/pnas.1913405117. View

Agurs-Collins T, Persky S, Paskett E, Barkin S, Meissner H, Nansel T . Designing and Assessing Multilevel Interventions to Improve Minority Health and Reduce Health Disparities. Am J Public Health. 2019; 109(S1):S86-S93. PMC: 6356127. DOI: 10.2105/AJPH.2018.304730. View

10.

Huber J, Ji M, Shih Y, Wang M, Colditz G, Chang S . Disentangling age, gender, and racial/ethnic disparities in multiple myeloma burden: a modeling study. Nat Commun. 2023; 14(1):5768. PMC: 10511740. DOI: 10.1038/s41467-023-41223-8. View

11.

Peres L, Colin-Leitzinger C, Teng M, Dutil J, Alugubelli R, DeAvila G . Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. Blood Adv. 2022; 6(12):3767-3778. PMC: 9631567. DOI: 10.1182/bloodadvances.2021006652. View

12.

Nachun D, Lu A, Bick A, Natarajan P, Weinstock J, Szeto M . Clonal hematopoiesis associated with epigenetic aging and clinical outcomes. Aging Cell. 2021; 20(6):e13366. PMC: 8208788. DOI: 10.1111/acel.13366. View

13.

Shah U, Moshier E, Derkach A, Huang Y, Mailankody S, Tan C . Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups. Blood Adv. 2023; 8(1):236-247. PMC: 10918423. DOI: 10.1182/bloodadvances.2023010815. View

14.

Stienen J, Ottevanger P, Wennekes L, van de Schans S, Dekker H, Blijlevens N . Delivering high-quality care to patients with a non-Hodgkin's lymphoma: barriers perceived by patients and physicians. Neth J Med. 2014; 72(1):41-8. View

15.

Flowers C, Shenoy P, Borate U, Bumpers K, Douglas-Holland T, King N . Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma. 2012; 54(2):268-76. PMC: 4151307. DOI: 10.3109/10428194.2012.708751. View

16.

Lin O, Shen M, Li C, Lee S . Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies. Cancer Causes Control. 2023; 34(10):883-886. DOI: 10.1007/s10552-023-01730-x. View

17.

Baughn L, Pearce K, Larson D, Polley M, Elhaik E, Baird M . Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry. Blood Cancer J. 2018; 8(10):96. PMC: 6180134. DOI: 10.1038/s41408-018-0132-1. View

18.

Lamy S, Bettiol C, Grosclaude P, Compaci G, Albertus G, Recher C . The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study. BMC Health Serv Res. 2016; 16(a):336. PMC: 4969648. DOI: 10.1186/s12913-016-1553-9. View

19.

Smith-Graziani D, Flowers C . Understanding and Addressing Disparities in Patients With Hematologic Malignancies: Approaches for Clinicians. Am Soc Clin Oncol Educ Book. 2021; 41:1-7. DOI: 10.1200/EDBK_320079. View

20.

Chen X, Shukla M, Saint Fleur-Lominy S . Disparity in hematological malignancies: From patients to health care professionals. Blood Rev. 2024; 65:101169. DOI: 10.1016/j.blre.2024.101169. View